Advertisement

Neuromodulators

  • Matthew J. GoldschmidtEmail author
  • Justin Clemow
Chapter

Abstract

One of the most common facial cosmetic procedures performed is the treatment of wrinkled skin using neuromodulators. This chapter describes the pharmacology of the most commonly used neuromodulators. Also covered are the basic techniques for dealing with the aging skin, and the potential complications of these procedures.

Keywords

Facial rhytids Botulinum toxin Dysport Botox Myobloc 

References

  1. 1.
  2. 2.
    Scott A, Rosenbaum A, Collins C. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol Vis Sci. 1973;12(12):924–7.Google Scholar
  3. 3.
    Scott A. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus. 1980;17(10):21–5.CrossRefGoogle Scholar
  4. 4.
    Scott A, Kennedy R, Stubbs H. Botulinum A toxin inection as a treatment for blepharospasm. Arch Ophyhlamol. 1985;103(3):347–50.CrossRefGoogle Scholar
  5. 5.
    Carruthers J, Fagien S, Mattarasso SL, et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114:1s–22s.CrossRefGoogle Scholar
  6. 6.
    Carruthers J, Carruthers J. Treatment of glabellar frown lineswith Clostridium botulinum A exotoxin. Dermatol Surg. 1992;18:17–21.CrossRefGoogle Scholar
  7. 7.
    Botox® (onabotulinumtoxin A) for injection. Prescribing Information. Irvine, CA: Allergan, Inc., 2017Google Scholar
  8. 8.
    Dysport (abotulinumtoxinA) for injection. Prescribing Information. Ipsen Pharmaceuticals and Galderma Laboratories, 2016Google Scholar
  9. 9.
    Xeomin (incobotulinumtoxinA) for injection. Prescribing Information, Franksville, WI: Merz Pharmaceuticals, LLC., 2010Google Scholar
  10. 10.
    David Crow, https://www.ft.com/content/49570b38-221f-11e8-9a70-08f715791301-,8 Mar 2018 (Financial Times Limited 2018)
  11. 11.
    Huang W, Foster J, Rogachefsky A. Pharmacology of botulinum toxin. J AmAcad Dermatol. 2000;43(2. Pt 1):249–59.CrossRefGoogle Scholar
  12. 12.
    Kane MAC. Chapter 3 Botulinum toxin. In: Neligan PC, Warren RJ, editors. Vol 2 Aesthetic surgery of plastic surgery. Philadelphia, PA: Elsevier Health Scineces; 2012.Google Scholar
  13. 13.
    Prescribing Information. Solstice Neurosciences, San Francisco, CA May, 2010Google Scholar
  14. 14.
    Kim A, Jung J, Pak A, Cutis 2013;(Suppl):12–18Google Scholar
  15. 15.
    Seeley BM, et al. Effects of homeopathic arnica montana on bruising in face-lifts. Arch Facial Plast Surg. 2006;8:54–9.CrossRefGoogle Scholar
  16. 16.
    Rowe DJ, Baker AC. Perioperative risks and benefits of herbal supplements in aesthetic surgery. Aesth Surg. 2009;29(2):150–7.CrossRefGoogle Scholar
  17. 17.
    Smith HS, Audette J, Royal MA. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain. 2002;18:S147.CrossRefGoogle Scholar
  18. 18.
    Guyer BM. Mechanism of botulinum toxin in the relief of pain. Curr Rev Pain. 1999;3:427.CrossRefGoogle Scholar
  19. 19.
    Ney J, Joseph K. Neurologic uses of botulinum neurotoxin type A. Neuropshychiatr Did Treat. 2007;3(6):785–98.Google Scholar
  20. 20.
    Truong D, Duaane D, Jankovic J, et al. The efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double blind, placebo controlled study. Mov Disord. 2005;20(7):783–91.CrossRefGoogle Scholar
  21. 21.
    Qaqish C. Botulinum toxin use in the upper face. Atlas Oral Maxillofacial Surg Clin N AM. 2016;24:95–103.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.The Cosmetic Surgery CenterIndependenceUSA
  2. 2.Case Western Reserve School of Dental Medicine, Metrohealth Medical CenterClevelandUSA

Personalised recommendations